United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
487.61
-2.63 (-0.54%)
Sep 4, 2026, 4:00 PM EDT - Market closed
United Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20,914 | 20,979 | 15,752 | 10,333 | 12,674 | 9,731 | |
Market Cap Growth | 14.23% | 33.18% | 52.44% | -18.47% | 30.24% | 44.26% |
Enterprise Value | 17,111 | 16,644 | 11,546 | 6,197 | 9,415 | 7,022 |
Last Close Price | 487.61 | 487.25 | 352.84 | 219.89 | 278.09 | 216.08 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.45 | 15.72 | 13.18 | 10.49 | 17.43 | 20.45 |
Forward PE | 18.85 | 17.14 | 12.17 | 9.93 | 13.57 | 13.45 |
PS Ratio | 6.63 | 6.59 | 5.48 | 4.44 | 6.55 | 5.77 |
PB Ratio | 3.25 | 2.96 | 2.44 | 1.73 | 2.64 | 2.46 |
P/TBV Ratio | 3.33 | 3.01 | 2.49 | 1.76 | 2.67 | 2.49 |
P/FCF Ratio | 19.13 | 20.16 | 14.58 | 13.82 | 19.10 | 20.38 |
P/OCF Ratio | 12.41 | 13.44 | 11.87 | 10.57 | 15.79 | 16.27 |
PEG Ratio | 2.65 | 4.43 | 1.02 | 13.47 | 1.03 | 0.72 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.42 | 5.23 | 4.01 | 2.66 | 4.86 | 4.17 |
EV/EBITDA Ratio | 11.44 | 10.39 | 7.58 | 4.99 | 9.05 | 9.53 |
EV/EBIT Ratio | 12.18 | 10.97 | 7.96 | 5.22 | 9.52 | 10.22 |
EV/FCF Ratio | 15.65 | 15.99 | 10.69 | 8.29 | 14.19 | 14.71 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | 0.01 | 0.05 | 0.12 | 0.17 | 0.20 |
Debt / EBITDA Ratio | - | 0.02 | 0.20 | 0.56 | 0.77 | 1.09 |
Debt / FCF Ratio | - | 0.04 | 0.28 | 0.94 | 1.21 | 1.68 |
Net Debt / Equity Ratio | -0.59 | -0.66 | -0.69 | -0.70 | -0.70 | -0.70 |
Net Debt / EBITDA Ratio | -2.54 | -2.91 | -2.91 | -3.39 | -3.22 | -3.77 |
Net Debt / FCF Ratio | -3.48 | -4.48 | -4.11 | -5.62 | -5.05 | -5.82 |
Asset Turnover | 0.42 | 0.42 | 0.40 | 0.35 | 0.35 | 0.35 |
Inventory Turnover | 2.41 | 2.26 | 2.30 | 2.41 | 1.55 | 1.36 |
Quick Ratio | 4.89 | 5.83 | 4.81 | 4.10 | 9.12 | 6.97 |
Current Ratio | 5.73 | 6.61 | 5.25 | 4.41 | 9.85 | 7.61 |
Return on Equity (ROE) | 19.31% | 19.71% | 19.23% | 18.27% | 16.61% | 12.94% |
Return on Assets (ROA) | 11.61% | 12.44% | 12.49% | 11.24% | 11.03% | 8.78% |
Return on Invested Capital (ROIC) | 31.28% | 30.73% | 31.45% | 28.48% | 27.09% | 21.21% |
Return on Capital Employed (ROCE) | 21.20% | 20.70% | 21.90% | 18.70% | 17.30% | 14.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.27% | 6.36% | 7.59% | 9.53% | 5.74% | 4.89% |
FCF Yield | 5.23% | 4.96% | 6.86% | 7.23% | 5.24% | 4.91% |
Buyback Yield / Dilution | 3.20% | 1.24% | 2.41% | -2.47% | -2.54% | -6.05% |